Cargando…
Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study
BACKGROUND: This study aimed to compare the live function change and adverse events (AEs) between drug-eluting beads (DEB) transarterial chemoembolization (TACE) with CalliSpheres(®) microspheres (CSM) and conventional TACE (cTACE) in treating hepatocellular carcinoma (HCC) patients. METHODS: Three...
Autores principales: | Xiang, Hua, Xiong, Bin, Li, Haiping, Zhao, Chang, Zhang, Zishu, Ma, Cong, Zheng, Chuansheng, Luo, Chao, Qiu, Huaiming, Yao, Yuanhui, Hu, Hongyao, Zhao, Hui, Long, Qingyun, Zhou, Jun, Chen, Changyong, Ma, Yilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799233/ https://www.ncbi.nlm.nih.gov/pubmed/35116944 http://dx.doi.org/10.21037/tcr.2019.09.15 |
Ejemplares similares
-
Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011) -
The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022) -
Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review
por: Ayyub, Javaria, et al.
Publicado: (2023) -
Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score
por: Zhu, Zi-yi, et al.
Publicado: (2022) -
Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
por: Yao, Man, et al.
Publicado: (2022)